Metz v. Commissioner of Social Security

District Court, N.D. Ohio·Decided September 26, 2022·No. 1:20-cv-02202·Unknown

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF OHIO EASTERN DIVISION

DANIEL WAYNE METZ, ) ) CASE NO. 1:20-cv-2202 Plaintiff, ) ) v. ) ) JUDGE DAVID A. RUIZ KILOLO KIJAKAZI, ) Acting Comm’r of Soc. Sec., ) ) MEMORANDUM OPINION AND ORDER Defendant. )

Plaintiff, Daniel Wayne Metz (Plaintiff), challenges the final decision of Defendant Kilolo Kijakazi, Acting Commissioner of Social Security (Commissioner),1 denying his applications for Disability Insurance Benefits (DIB) and Supplemental Security Income (SSI) under Titles II and XVI of the Social Security Act, 42 U.S.C. §§ 416(i), 423, 1381 et seq. (Act). This court has jurisdiction pursuant to 42 U.S.C. § 405(g). For the reasons set forth below, the Commissioner’s final decision is AFFIRMED. I. Procedural History On September 25, 2018, Plaintiff protectively applied for DIB and SSI, alleging a disability onset date of August 20, 2018. (R. 12 PageID# 246-52, Transcript (Tr.) 179-185). The applications were denied initially and upon reconsideration, and Plaintiff requested a hearing before an Administrative Law Judge (ALJ). (Tr. 55-124, 175-178). Plaintiff participated in the hearing on March 19, 2019, was represented by counsel, and testified. (Tr. 34-54). A vocational

1 Pursuant to Rule 25(d), the previous “officer’s successor is automatically substituted as a party.” Fed.R.Civ.P. 25(d). ex pert (VE) also participated and testified. Id. On November 29, 2019, the ALJ found Plaintiff not disabled. (Tr. 17-33). On August 13, 2020, the Appeals Council denied Plaintiff’s request to review the ALJ’s decision, and the ALJ’s decision became the Commissioner’s final decision. (Tr. 6-8). Plaintiff’s complaint challenges the Commissioner’s final decision. (R. 1). The parties have completed briefing in this case. (R. 14, R. 15). Plaintiff asserts the following assignment of error: the ALJ’s residual functional capacity (RFC) assessment is contrary to law and unsupported by substantial evidence because of the ALJ’s alleged failure to properly evaluate the medical opinion evidence. (R. 14 PageID# 687, 697, 701). II. Evidence2 A. Relevant Medical Evidence 1. Treatment Records On October 27, 2017, prior to his August 20, 2018 alleged onset date, Plaintiff established treatment with psychiatric mental health nurse practitioner Anthony Shumway, PMHNP-BC (Tr.

387), who diagnosed Plaintiff with major depressive disorder, recurrent, moderate; attention- deficit hyperactivity disorder, predominantly inattentive type; insomnia, unspecified and generalized anxiety disorder. (Tr. 395). Nurse Shumway also prescribed a trial of mirtazapine and recommended Plaintiff continue with therapy, however, Plaintiff was hesitant due to his busy work schedule. Id. He prescribed new medications and/or doses in May 2018 (Tr. 397-98), June 2018 (Tr. 380-81), July 2018 (Tr. 381) and August 2018 (Tr. 381-82), concluding on

2 While the Court has thoroughly reviewed the pertinent medical records and hearing testimony, this recitation of the evidence is intended only to serve as a succinct summary of Plaintiff’s medical conditions, treatment, and opinions rendered that are directly germane to the assignment of error raised. A ugust 4, 2018, that Plaintiff could work without restrictions. (Tr. 382). He again adjusted Plaintiff’s medications on August 25, 2018—five days after Plaintiff’s alleged onset date—to address signs and symptoms of depression, anxiety and insomnia. (Tr. 382). From September 30 to October 5, 2018, Plaintiff required inpatient hospitalization for passive suicidal ideation after drinking wine and then presenting with a depressed mood and constricted affect. (Tr. 296-99). Plaintiff also endorsed increased impulsivity, hostility, hopelessness, panic attacks, decreased concentration, decreased sleep and increased alcohol use. (Tr. 333). Plaintiff’s treatment plan included group and individual therapy and medication titration. (Tr. 337-40). At discharge, Plaintiff reported his medication worked, he denied suicidal thoughts, his concentration was within normal limits, and he maintained goal-oriented thought processes with intact memory and fair insight and judgment. (Tr. 342). On October 20, 2018, nurse Shumway noted Plaintiff endorsed “through the roof” anxiety and forgetfulness but otherwise endorsed 0/10 depression and denied crying spells, hopelessness, mood swings, mania, suicidal ideation or increased sleep. (Tr. 379). On December 8, 2018,

Plaintiff presented as severely distracted and required frequent redirection and refocusing (Tr. 422), while on February 23, 2019, Plaintiff’s mental status testing revealed mild to moderate impaired memory, abnormal psychomotor activity, poor attention/concentration, significant distractibility, and he reported depressed mood with increased marijuana use. (Tr. 417, 547). On March 23, 2019, nurse Shumway reintroduced Clonidine to target motor restlessness, insomnia, anxiety and ADHD, in addition to paroxetine, sertraline, Depakote ER and Clonazepam. (Tr. 560). Beginning May 18, 2019, nurse Shumway provided monthly medication management, with continued medication changes after Plaintiff acknowledged he was doing “fine” until he could no t fill his Clonazepam. (Tr. 565, 572). Plaintiff endorsed “doing awesome” (Tr. 575) with “100% better” mood, and the ability to leave his home to see a show despite continued anxiety fluctuations, without panic attacks since taking all of his prescribed medications in June 2019. (Tr. 576). On July 20, 2019, Plaintiff endorsed a decrease in crying spells, two minor panic attacks with medication, and depression rated at 3-4/10 since the last appointment. (Tr. 586). Nurse Shumway added a prescription for Vyvanse and, a month later, noted “[V]yvanse was very efficacious for ADHD s/sx; less restless in office today, marked improvement vs. last time. [F]inished 9 paintings since last time and better able to keep up w/ housework since [V]yvanse.” (Tr. 597). Plaintiff continued to improve on Vyvanse and presented with markedly less fidgeting and less restlessness in September 2019. (Tr. 610). 2. Medical Opinions Concerning Plaintiff’s Functional Limitations On December 29, 2018, State agency consultative psychologist Michael E. Cremerius, Ph.D., opined Plaintiff had mild limitations in his ability to understand, remember or apply

Free access — add to your briefcase to read the full text and ask questions with AI

Metz v. Commissioner of Social Security, (N.D. Ohio 2022).

Metz v. Commissioner of Social Security (Metz v. Commissioner of Social Security) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

National Labor Relations Board v. Wyman-Gordon Co.
394 U.S. 759 (Supreme Court, 1969)
Kirk v. Secretary of Health and Human Services
667 F.2d 524 (Sixth Circuit, 1981)
Ruby E. Heston v. Commissioner of Social Security
245 F.3d 528 (Sixth Circuit, 2001)
Joseph Branon v. Commissioner of Social Security
539 F. App'x 675 (Sixth Circuit, 2013)
Ealy v. Commissioner of Social Security
594 F.3d 504 (Sixth Circuit, 2010)
White v. Commissioner of Social Security
572 F.3d 272 (Sixth Circuit, 2009)
McClellan v. Astrue
804 F. Supp. 2d 678 (E.D. Tennessee, 2011)
Martin v. Commissioner of Social Security
170 F. App'x 369 (Sixth Circuit, 2006)
United States v. Elder
90 F.3d 1110 (Sixth Circuit, 1996)
McPherson v. Kelsey
125 F.3d 989 (Sixth Circuit, 1997)
McLamb v. Keane
523 U.S. 1050 (Supreme Court, 1998)